mivacurium

Known as: mivacurium [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
UNLABELLED Patients with pseudocholinesterase (BChE) variants may exhibit markedly prolonged paralysis after the administration… (More)
Is this relevant?
2001
2001
BACKGROUND AND OBJECTIVE To test the hypothesis that magnesium sulphate reduces the amount of remifentanil needed for general… (More)
Is this relevant?
2000
2000
BACKGROUND The duration of action for many pharmaceutical agents is dependent on their breakdown by endogenous hydrolytic enzymes… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
This study compares the emergence and recovery characteristics of sevoflurane, desflurane, and halothane in children undergoing… (More)
Is this relevant?
1995
1995
We have examined the effects of different benzyl-isoquinolinium and steroidal neuromuscular blocking compounds on plasma… (More)
Is this relevant?
1994
1994
We have used mivacurium in four myasthenic patients presenting for thymectomy. Supramaximal single twitch stimulation was applied… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1994
1994
We have studied the interaction between atracurium and mivacurium. The dose-response relationships of atracurium, mivacurium and… (More)
Is this relevant?
1994
1994
Different priming sequences of equipotent doses of rocuronium and mivacurium on the onset of maximum neuromuscular block and… (More)
  • table I
  • table II
Is this relevant?
1993
1993
The duration of action of mivacurium was evaluated during a modified neurolept anaesthesia in 17 patients heterozygous for the… (More)
Is this relevant?
1989
1989
Mivacurium is a new short-acting competitive neuromuscular blocking agent. Infusion requirements for the maintenance of a stable… (More)
Is this relevant?